Bridgehead
Consulting has prepared expert reports for, amongst others:
-
GeneMedix Ltd (UK and Singapore)
The first company to float simultaneously on the UK
and Singapore stock exchanges.
The company's principal activity is the manufacture and marketing of generic versions
of therapeutic proteins using recombinant DNA technology.
The rationale for the company is to manufacture these
proteins to Western GMP standards in low cost base facilities
in several countries for initial target markets in China,
India, ASEAN countries and Eastern Europe.
-
GW Pharmaceuticals Ltd (UK)
-
Akers Bioscience Ltd (UK)
-
Develops, produces and sells a wide
range of point of care diagnostic, screening and testing
products based on its validated PIFA (Particle Immuno-filtration
assay) and MPC (Micro particle catalysed) Biosensor
technologies.
To differentiate itself from major diagnostic companies, Akers concentrates
on disease specific diagnostics targeted at the physician
or consumer, diagnostics aimed at managing problems associated
with existing drug therapies and diagnostic tools to help
pharmaceutical companies in product development.
The objectives for the client
For each individual expert report there
will be specific objectives related to the nature of the
company's business. However, each expert report covers:
-
project merits
-
risk factors
-
commercial potential
-
development plans.
|
|
The programme of work
In the production of expert reports the
deliverables are clearly defined, needing to conform to
required legal standards. Bridgehead Consulting has a tried
and tested method for developing expert reports based on
a clear template for their format and content. In most cases
the expert report is based on a fully documented and referenced
long form, or due diligence study, ensuring traceability
of all information put forward. In addition, Bridgehead
Consulting ensures that it identifies the right team of
consultants and associates for the individual project, based
on expertise, experience and technical background.
Project
deliverables and achievements |
|
Publishable expert report within the
company's placing prospectus. Since investment decisions
will be based on the contents of the prospectus, any
statement within the expert report will need verification
and Bridgehead Consulting provides referenced evidence.
Added value
Bridgehead Consulting's well proven
methodology, past experience, familiarity with the flotation
process and requirements and the availability of a wide
range of technical and commercial expertise, allows
the preparation of expert reports to a high standard
and, if required, to short timescales. |
| |
|